Sicor Will Offer Common Shares

Sicor Inc., an Irvine maker of injectable drugs, has registered to offer more than 9.5 million common shares on behalf of five selling stockholders, according to a shelf registration filed with the Securities and Exchange Commission. The offer included 867,500 shares that can be issued upon exercise of warrants to investors at $5.75 per share. The proposed maximum offering price is $4.59 a share. The primary selling stockholders are Stamford Investments Ltd., with 5.75 million shares of common stock and warrants worth 575,000 shares, and Carlo Salvi, with 2.5 million shares and warrants worth 250,000 shares.